Zhu Shuai-Ming, Gao Chun-Xue, Jin Zi-Jia, Luo Fu-Yao, Feng Ting, Li Jing-Cao, Yang Yu, Xu Rui, Ma Hao, Li Chang-Wei, Xue Rui, Shan Jun-Jie, Zhang You-Zhi
Beijing Institute of Pharmacology and Toxicology Beijing China.
North China University of Science and Technology Tangshan China.
Food Sci Nutr. 2025 Sep 3;13(9):e70819. doi: 10.1002/fsn3.70819. eCollection 2025 Sep.
Baichuan Baile (BCBL) is a novel formula that incorporates three herbs and a single food additive, all of which are widely used in ordinary or functional foods. It is a promising dietary supplement for the treatment of depression based on TCM principles and nutritional assessments. Our study was designed to explore BCBL's antidepressant-like effects and elucidate its underlying mechanisms. First, the antidepressant-like effects of BCBL were predicted through network pharmacology and validated using systematic depression models. Next, the 5-HTP-induced head-twitch test, yohimbine-induced death test, and reserpine-induced ptosis, hypothermia, and akinesia test were conducted to assess BCBL's impact on monoaminergic function. Additionally, the effects of BCBL on monoamine neurotransmitters were measured using HPLC-ECD and ELISA. As a result, an integrated analysis using the TCMSP and Genecards databases identified 37 active components sharing 192 targets associated with depression. Further construction of the PPI network, along with GO and KEGG enrichment analyses, revealed a comprehensive and synergistic interaction between BCBL and depression, also predicting that the serotoninergic system might partially mediate the antidepressant-like effects of BCBL. Subsequent pharmacological tests indicated that BCBL demonstrated significant antidepressant-like effects on behavioral despair mice, CRS and CNE-induced depression-like mice, and chronic reserpine-induced depression-like mice. The DDI tests, HPLC-ECD, and ELISA analyses validated that BCBL's antidepressant-like effects were mediated through upregulation of the serotoninergic system. Our findings provided a safe and effective candidate for the amelioration of depression that deserves further investigations and explorations.
百川百乐(BCBL)是一种新型配方,包含三种草药和一种单一的食品添加剂,所有这些成分都广泛应用于普通食品或功能性食品中。基于中医原理和营养评估,它是一种有前景的用于治疗抑郁症的膳食补充剂。我们的研究旨在探索BCBL的抗抑郁样作用并阐明其潜在机制。首先,通过网络药理学预测BCBL的抗抑郁样作用,并使用系统性抑郁症模型进行验证。接下来,进行5-羟色氨酸诱导的头部抽搐试验、育亨宾诱导的死亡试验以及利血平诱导的眼睑下垂、体温过低和运动不能试验,以评估BCBL对单胺能功能的影响。此外,使用高效液相色谱-电化学检测法(HPLC-ECD)和酶联免疫吸附测定法(ELISA)测量BCBL对单胺神经递质的影响。结果,使用中药系统药理学数据库(TCMSP)和基因卡片(Genecards)数据库进行的综合分析确定了37种活性成分,它们共享192个与抑郁症相关的靶点。进一步构建蛋白质-蛋白质相互作用(PPI)网络以及基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析,揭示了BCBL与抑郁症之间全面且协同的相互作用,还预测血清素能系统可能部分介导BCBL的抗抑郁样作用。随后的药理学试验表明,BCBL对行为绝望小鼠、慢性应激(CRS)和慢性神经炎症(CNE)诱导的抑郁样小鼠以及慢性利血平诱导的抑郁样小鼠具有显著的抗抑郁样作用。药物相互作用(DDI)试验、HPLC-ECD和ELISA分析证实,BCBL的抗抑郁样作用是通过上调血清素能系统介导的。我们的研究结果为改善抑郁症提供了一种安全有效的候选物,值得进一步研究和探索。